A new study conducted by research scientists from the University of Basel, Switzerland, and the Cardiovascular Research Institute of Basel (CRIB), hypothesized that “COVID-19 mRNA-vaccine-associated myocardial injury following booster vaccination may be much more common, as symptoms may be unspecific, mild or even absent, escaping passive surveillance.”
The study’s research suggests that that hypothesis is correct, as evidence of myocarditis—a potentially fatal inflammation of the heart—was observed in 1 in 35 subjects who received the mRNA COVID-19 vaccine booster, with 1 in 20 showing indications of having suffered some kind of heart injury.
Of the 777 subjects that participated in the study, all of whom were medical professionals (70% of whom were women) at the median age of 37 who received the Moderna COVID-19 mRNA vaccine, 2.8% had elevated cardiac troponin proteins present in their bloodstream three days after receiving the shot, indicating damage to the heart muscle had indeed taken place.
“Our findings confirmed the study hypothesis. mRNA-1273 booster vaccination-associated elevation of markers of myocardial injury occurred in about one out of 35 persons (2.8%), a greater incidence than estimated in meta-analyses of hospitalized cases with myocarditis (estimated incidence 0.0035%) after the second vaccination,” the research scientists wrote.
As the Canadian Catholic LifeSiteNews reported:
Previously it was maintained by health authorities—such as the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA)—that such injuries from the COVID “vaccines” affected only one in 666, or 1,500 cases in every million receiving the injections.
The worrying findings of the study, titled “Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination,” have been published in the international, peer-reviewed European Journal of Heart Failure, which is the open-access journal of the Heart Failure Association of the European Society of Cardiology…Source – Read More!